Tags

Type your tag names separated by a space and hit enter

Ascorbic acid supplements and kidney stone incidence among men: a prospective study.

Links

  • Publisher Full Text
  • Authors

    , , , ,

    Source

    JAMA internal medicine 173:5 2013 Mar 11 pg 386-8

    MeSH

    Aged
    Ascorbic Acid
    Calcium Oxalate
    Cohort Studies
    Dietary Supplements
    Dose-Response Relationship, Drug
    Humans
    Incidence
    Kidney Calculi
    Male
    Middle Aged
    Proportional Hazards Models
    Prospective Studies
    Risk Assessment
    Sweden
    Vitamins

    Pub Type(s)

    Letter
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    23381591

    Citation

    Thomas, Laura D K., et al. "Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: a Prospective Study." JAMA Internal Medicine, vol. 173, no. 5, 2013, pp. 386-8.
    Thomas LD, Elinder CG, Tiselius HG, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013;173(5):386-8.
    Thomas, L. D., Elinder, C. G., Tiselius, H. G., Wolk, A., & Akesson, A. (2013). Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Internal Medicine, 173(5), pp. 386-8. doi:10.1001/jamainternmed.2013.2296.
    Thomas LD, et al. Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: a Prospective Study. JAMA Intern Med. 2013 Mar 11;173(5):386-8. PubMed PMID: 23381591.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Ascorbic acid supplements and kidney stone incidence among men: a prospective study. AU - Thomas,Laura D K, AU - Elinder,Carl-Gustaf, AU - Tiselius,Hans-Göran, AU - Wolk,Alicja, AU - Akesson,Agneta, PY - 2013/2/6/entrez PY - 2013/2/6/pubmed PY - 2013/4/27/medline SP - 386 EP - 8 JF - JAMA internal medicine JO - JAMA Intern Med VL - 173 IS - 5 SN - 2168-6114 UR - https://www.unboundmedicine.com/medline/citation/23381591/full_citation L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2013.2296 DB - PRIME DP - Unbound Medicine ER -